Changes in the utilisation of lipid-lowering drugs over a 6-year period (1993-1998) in a Danish population

European Journal of Clinical Pharmacology

Volumn 57, Issue 4, 2001, Pages 343-348

  Larsen, John ^b   Andersen, Morten ^a   Kragstrup, Jakob ^a   Gram, Lars F ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b NONE

Author keywords

Lipid lowering drug utilisation; Prescription database; Statins

Indexed keywords

ANTILIPEMIC AGENT; ANTIOBESITY AGENT; SIMVASTATIN;

ADULT; AGED; ARTICLE; DRUG UTILIZATION; FEMALE; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; MALE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; REIMBURSEMENT; SWEDEN;

AGED; ANTILIPEMIC AGENTS; DENMARK; DRUG UTILIZATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS;

EID: 0034901508     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280100307     Document Type: Article

References (22)

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
2. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group
3. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
4. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
5. Has interest in secondary prevention increased among physicians after the 4S study?
6. Use of lipid-lowering drugs from 1990 to 1994: An international comparison among Australia, Finland, Italy (Emilia Romagna Region), Norway and Sweden
7. The Danish prescription registries
8. Guidelines accompanied by changes of reimbursement rules. Effects on lipid-lowering drug prescribing
9. Lack of adherence to lipid-lowering drug treatment. A comparison of utilization patterns in defined populations in Funen, Denmark and Bologna, Italy
10. The waiting time distribution as a graphical approach to epidemiologic measures of drug utilization
11. The prescribing of lipid lowering drugs during a 1-year period: Analysis of 7490 health insurance files
12. Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons
13. Time trends in the use of cholesterol-lowering agents in older adults: The Cardiovascular Health Study
14. Growth in use of statins after trials is not targeted to most appropriate patients
15. Recent trends in the consumption of lipid-lowering drugs in Finland
16. A drug utilisation study investigating prescribed daily doses of hypolipidaemic agents
17. Lipid-lowering drugs in the management of hyperlipidaemia